Last reviewed · How we verify
Epidural analgesia for labour pain
At a glance
| Generic name | Epidural analgesia for labour pain |
|---|---|
| Also known as | labor epidural, labour epidural |
| Sponsor | Helsinki University Central Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cross-legged Versus Traditional Sitting Position for the Success of Epidural Analgesia During Labor (NA)
- SKIN WHEAL - Subcutaneous or Intradermal Lidocaine in Epidural for Laboring Pain. (NA)
- Comparing PIEB and CEI for Labor Pain Relief (NA)
- Incidence and Factors Involving Cesarean Delivery After Epidural Analgesia for Labor
- Maternal Expectations on Labor Analgesia and Risk of Postpartum Depression: An Observational Study
- Maternal and Fetal Clinical Significance of Hypotension Following Labor Epidural Analgesia
- Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia (PHASE4)
- EPIDURAL- Evaluation of Preexisting Information Regarding Neuroaxial Procedures for Labour Analgesia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: